Results
91
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
91 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.39 | -2.8% | 5.3% | SEK 376.9m | SEK 2.20 | PS3.3x | E86.1% | n/a | Tech | ||
CALTX | SEK 207.00 | 0.2% | 115.8% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 310.00 | 4.0% | 211.9% | SEK 26.7b | SEK 295.00 | PE137.7x | E43.7% | n/a | Software | ||
MAGLE | SEK 37.60 | -0.5% | 24.5% | SEK 406.1m | SEK 50.00 | PE52.8x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 286.00 | -1.0% | 27.7% | SEK 3.6b | n/a | PE35.2x | E24.8% | 1.9% | Capital Goods | ||
TRUE B | SEK 36.64 | 2.5% | 7.4% | SEK 12.6b | SEK 57.20 | PE26.5x | E21.6% | 1.1% | Software | ||
FNOX | SEK 57.52 | 2.3% | 1.8% | SEK 35.1b | SEK 77.88 | PE54x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 161.30 | 5.6% | -49.8% | SEK 14.2b | SEK 320.40 | PS56.5x | E102.8% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.60 | -6.7% | -69.6% | SEK 218.2m | SEK 7.90 | PS29.9x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.23 | -3.0% | -21.8% | SEK 241.2m | SEK 2.84 | PS2.2x | E115.5% | n/a | Tech | ||
CRAD B | SEK 43.55 | -1.0% | 40.3% | SEK 1.5b | SEK 57.00 | PE27.3x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.10 | -0.3% | -24.8% | SEK 304.2m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
CTM | SEK 7.38 | 10.3% | -57.2% | SEK 558.3m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
ESGR B | SEK 29.90 | 0.3% | -58.8% | SEK 196.9m | SEK 58.00 | PS1.1x | E57.0% | n/a | Household | ||
FLEXQ | SEK 11.00 | -6.4% | -39.2% | SEK 147.4m | SEK 25.00 | PS1.3x | E118.7% | n/a | Capital Goods | ||
EQT | SEK 348.50 | 3.5% | 65.1% | SEK 411.8b | SEK 361.36 | PE119.9x | E56.8% | 1.0% | Diversified Financials | ||
MIDS | SEK 1.21 | -3.8% | -38.6% | SEK 253.8m | SEK 2.80 | PS3.9x | E89.9% | n/a | Semiconductors | ||
KLAR | SEK 0.48 | -4.7% | -12.7% | SEK 62.5m | SEK 1.00 | PB3x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 17.85 | -5.6% | -29.6% | SEK 627.1m | SEK 22.00 | PS2.1x | E108.0% | n/a | Software | ||
SENZA | SEK 7.55 | 6.3% | -13.0% | SEK 222.8m | SEK 16.00 | PS4x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
GIAB | SEK 0.72 | 0.7% | -66.7% | SEK 11.3m | SEK 1.71 | PE-0.9x | E72.9% | n/a | Commercial Services | ||
EGTX | SEK 5.72 | 10.4% | 36.5% | SEK 1.7b | SEK 11.40 | PS23.6x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.48 | -12.0% | -47.4% | SEK 180.6m | n/a | PS1.9x | E67.2% | n/a | Software |